Get Started

NVS

NYSE Novartis AG Sponsored ADR
Nov 1, 2026 · 5:41 PM ET EOD Market Closed

$160.79 ↑ +0.00 (+0.00%) Trading Up from the previous close of $160.79, $3.27 below the day’s high of $164.06

YTD change
+16.62%
vs 20-day SMA
+7.91%
vs 200-day SMA
+5.97%

Price ranges

Previous day
$160.40 $164.06
open $162.65 close $160.79
-$1.86 (-1.14%)
Today
$160.40 $164.06
$160.79
Past week
$149.17 $162.19
from $156.27 now $160.79
+$4.52 (+2.89%)
Past month
$139.31 $162.19
from $141.05 now $160.79
+$19.74 (+14.00%)
This year
$135.55 $170.46
from $137.87 now $160.79
+$22.92 (+16.62%)

Price & Performance

+14.22 (+9.70%) / 6M

$135.09$145.11$155.14$165.16May 1Aug 3Oct 30

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 5.7% away from all-time highs of $170.46
  • NVS is up 17% since the beginning of the year
  • NVS is up 31% over the past 12 months
  • NVS is up 14% over the past 1 month
  • 0% of all NVS investors are betting against NVS
  • Number of investors short NVS has gone down 1% versus last month

NVS reads very good: price sits above both the 20- and 200-day averages, short interest is falling month over month, the 12-month move is +29.8%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $2.46
Earnings momentum -10.0% Quarterly EPS growth
Quarterly change -10.0%

Valuation

P/E ratio 29.79
Enterprise value $346.6B
Beta 0.19

Balance sheet & scale

Income$10.0M
Revenue$55.4B
Cash$9.0B
Debt$48.3M
Income / Debt 0.21×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNYSE
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $294.3B

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,417.54 +3.19%
JNJ Johnson & Johnson $273.20 -0.73%
ABBV AbbVie, Inc. $294.89 +1.41%
MRK Merck & Co., Inc. $149.52 +2.18%
RHHBY Roche Holding Ltd Sponsored ADR $61.27 +0.82%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.